TGA takes strong action to protect Australians from unlawful therapeutic goods

TGA

The Therapeutic Goods Administration (TGA) has released its 2025-26 Regulatory Compliance Statistics, highlighting action taken to protect Australians from unlawful, unsafe and unapproved therapeutic goods.

The results demonstrate the scale of the TGA’s compliance, enforcement, border protection and education activities between 1 July 2025 to 30 June 2026.

During the year, the TGA:

  • assessed and triaged more than 27,700 reports of alleged unlawful therapeutic goods activity
  • undertook more than 18,500 compliance interventions, including warning letters, infringement notices and disruption of unlawful online activities
  • worked with border and law enforcement partners to seize and destroy 13.6 million unlawfully imported therapeutic goods, and
  • facilitated the release of more than 3 million therapeutic goods, helping to maintain access under legitimate pathways by Australian importers.

The TGA’s regulatory activities spanned advertising, importation and supply of unlawful therapeutic goods, with a focus on products presenting the greatest risk to public health. Further information on the TGA’s compliance approach is available in the TGA’s Compliance Principles 2026 and 2027 and our Regulatory Compliance Framework.

Beyond enforcement, the TGA continued to support consumers, health professionals and industry through education and guidance. During the year, the TGA issued safety alerts on emerging risks including unapproved peptide products, counterfeit medicines and medicines containing dangerous substances.

This information does not reflect all TGA compliance activities. See Managing regulatory compliance and other published compliance actions and outcomes

/Public Release. View in full here.